Quadrant Capital Group’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-175
| Closed | -$17.8K | – | 2788 |
|
|
2023
Q2 | $17.8K | Sell |
175
-93
| -35% | -$9.48K | ﹤0.01% | 1770 |
|
|
2023
Q1 | $24.4K | Hold |
268
| – | – | ﹤0.01% | 1591 |
|
|
2022
Q4 | $10.2K | Sell |
268
-17
| -6% | -$646 | ﹤0.01% | 1941 |
|
|
2022
Q3 | $7K | Sell |
285
-5,600
| -95% | -$138K | ﹤0.01% | 2048 |
|
|
2022
Q2 | $179K | Sell |
5,885
-19,997
| -77% | -$608K | 0.02% | 457 |
|
|
2022
Q1 | $848K | Buy |
25,882
+5,856
| +29% | +$192K | 0.1% | 151 |
|
|
2021
Q4 | $528K | Buy |
20,026
+20,013
| +153,946% | +$528K | 0.06% | 203 |
|
|
2021
Q3 | $1K | Hold |
13
| – | – | ﹤0.01% | 2436 |
|
|
2021
Q2 | $2K | Buy |
13
+3
| +30% | +$462 | ﹤0.01% | 2182 |
|
|
2021
Q1 | $1K | Sell |
10
-15
| -60% | -$1.5K | ﹤0.01% | 2337 |
|
|
2020
Q4 | $3K | Buy |
25
+15
| +150% | +$1.8K | ﹤0.01% | 1892 |
|
|
2020
Q3 | $1K | Sell |
10
-6
| -38% | -$600 | ﹤0.01% | 2107 |
|
|
2020
Q2 | $2K | Buy |
+16
| New | +$2K | ﹤0.01% | 1984 |
|